Literature DB >> 2353827

Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment.

T Uematsu1, R Sato, O Fujimori, M Nakashima.   

Abstract

We report a method for determining haloperidol concentration in human scalp hair and discuss a possible linkage of haloperidol excretion into hair with the hair pigment melanin. First, an animal study was conducted to support the idea that hair contains amounts of haloperidol corresponding to the doses given and pigmented hair contains much more drug than does unpigmented hair. The haloperidol concentration was measured using a radioimmunoassay technique after hairs were dissolved in 2.5 N NaOH solution and the drug extracted. Pigmented and albino rats, whose hair from an area on the back had been removed beforehand by plucking, were administered either 1, 3, or 10 mg of haloperidol (i.p.) per kg body weight every day for 3 weeks. At the end of the administration period hair which had newly grown on the denuded area was plucked and collected. In each of the two groups classified by hair color the drug levels in the hair correlated with the doses given; however, the concentrations in the hair from the albino rats were much lower than those in the hair from the pigmented rats (which was less than 8.5%). Second, black and white hair was collected from each of seven human subjects with grizzled hair, who were receiving or had been administered haloperidol at fixed daily doses for more than 1 month, and the concentration of haloperidol in each type of hair was measured. In the same subject the concentration in the white hair was found to be much lower than that in the black (less than 10%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353827     DOI: 10.1007/bf00493470

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

1.  Chronic plumbism in children. Diagnosis by hair analysis.

Authors:  L Kopito; A M Briley; H Shwachman
Journal:  JAMA       Date:  1969-07-14       Impact factor: 56.272

2.  Trace metals in human hair.

Authors:  H A Schroeder; A P Nason
Journal:  J Invest Dermatol       Date:  1969-07       Impact factor: 8.551

3.  Pharmacokinetic studies on haloperidol in man.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

4.  Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.

Authors:  R Rimón; I Averbuch; P Rozick; L Fijman-Danilovich; T Kara; H Dasberg; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.

Authors:  T Uematsu; R Sato; K Suzuki; S Yamaguchi; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

7.  Detection of phencyclidine in hair.

Authors:  A M Baumgartner; P F Jones; C T Black
Journal:  J Forensic Sci       Date:  1981-07       Impact factor: 1.832

8.  Haloperidol kinetics after oral and intravenous doses.

Authors:  F O Holley; J R Magliozzi; D R Stanski; L Lombrozo; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

9.  Determination of haloperidol in human serum by radioimmunoassay.

Authors:  H Suzuki; Y Minaki; M Iwaisaki; Y Sekine; A Kagemoto; Y Utsui; M Hashimoto; G Yagi; H Itoh
Journal:  J Pharmacobiodyn       Date:  1980-05

10.  Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.

Authors:  R C Smith; R Baumgartner; C H Misra; M Mauldin; A Shvartsburd; B T Ho; C DeJohn
Journal:  Arch Gen Psychiatry       Date:  1984-11
View more
  10 in total

Review 1.  A discourse on human hair fibers and reflections on the conservation of drug molecules.

Authors:  L Pötsch
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

2.  Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs.

Authors:  K Kosuge; T Uematsu; S I Araki; H Matsuno; K Ohashi; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Ultrastructural alterations and environmental exposure influence the opiate concentrations in hair of drug addicts.

Authors:  L Pötsch; G Skopp; J Becker
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

Review 4.  Therapeutic drug monitoring in hair samples. Principles and practice.

Authors:  T Uematsu
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

5.  The measurement of ofloxacin in hair as an index of exposure.

Authors:  T Uematsu; N Miyazawa; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.

Authors:  H Sato; T Uematsu; K Yamada; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.

Authors:  M Nakano; T Uematsu; H Sato; K Kosuge; M Nishimoto; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  The measurement of a new antimicrobial quinolone in hair as an index of drug exposure.

Authors:  T Uematsu; M Nakano; H Akiyama; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

9.  The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking-cessation programme with or without the aid of nicotine chewing gum.

Authors:  T Uematsu; A Mizuno; S Nagashima; A Oshima; M Nakamura
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

10.  Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.

Authors:  T Uematsu; Y Ohsawa; A Mizuno; M Nakashima
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.